Portfolio company
Romix Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
Flomics
Flomics develops liquid biopsy blood tests and a bioinformatics platform for early cancer detection in clinical and research settings.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
AOA Diagnostics
This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
